EP3290423 - OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 27.05.2022 Database last updated on 31.08.2024 | |
Former | The patent has been granted Status updated on 18.06.2021 | ||
Former | Grant of patent is intended Status updated on 09.02.2021 | ||
Former | Examination is in progress Status updated on 17.04.2020 | ||
Former | Request for examination was made Status updated on 02.02.2018 | Most recent event Tooltip | 14.06.2024 | Lapse of the patent in a contracting state New state(s): TR | published on 17.07.2024 [2024/29] | Applicant(s) | For all designated states Jiangsu Vcare Pharmatech Co., Ltd No. 15 Wanshou Road Pukou Hi-Tech Industrial Development Zone Nanjing, Jiangsu 210061 / CN | [2018/10] | Inventor(s) | 01 /
SUN, Hongbin c/o Jiangsu Vcare Pharmatech Co., Ltd No. 15 Wanshou Road Pukou Hi- Tech Industrial Development Zone Nanjing, Jiangsu 210061 / CN | 02 /
SHAN, Jiaqi c/o Jiangsu Vcare Pharmatech Co., Ltd No. 15 Wanshou Road Pukou Hi- Tech Industrial Development Zone Nanjing, Jiangsu 210061 / CN | 03 /
ZHANG, Boyu c/o Jiangsu Vcare Pharmatech Co., Ltd No. 15 Wanshou Road Pukou Hi-Tech Industrial Development Zone Nanjing, Jiangsu 210061 / CN | 04 /
YUAN, Fang c/o Jiangsu Vcare Pharmatech Co., Ltd No. 15 Wanshou Road Pukou Hi-Tech Industrial Development Zone Nanjing, Jiangsu 210061 / CN | [2018/10] | Representative(s) | Lang, Johannes Bardehle Pagenberg Partnerschaft mbB Patentanwälte, Rechtsanwälte Prinzregentenplatz 7 81675 München / DE | [2018/10] | Application number, filing date | 17172160.8 | 28.01.2011 | [2018/10] | Priority number, date | CN201010104091 | 02.02.2010 Original published format: CN201010104091 | CN201010624329 | 30.12.2010 Original published format: CN201010624329 | [2018/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3290423 | Date: | 07.03.2018 | Language: | EN | [2018/10] | Type: | B1 Patent specification | No.: | EP3290423 | Date: | 21.07.2021 | Language: | EN | [2021/29] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 24.11.2017 | Classification | IPC: | C07D495/04, A61K31/4365, A61P7/02 | [2018/10] | CPC: |
C07D495/04 (EP,KR,US);
A61K31/4365 (EP,KR,US);
A61K9/08 (KR);
A61K9/14 (KR);
A61K9/20 (KR);
A61K9/48 (KR);
A61P7/00 (EP);
A61P7/02 (EP);
A61P9/00 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/10] | Title | German: | OPTISCH AKTIVE 2-HYDROXY-TETRAHYDROTHIEN-PYRIDIN-DERIVATE, HERSTELLUNGSVERFAHREN UND VERWENDUNG BEI DER MEDIKAMENTENHERSTELLUNG | [2018/10] | English: | OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF | [2018/10] | French: | DÉRIVÉS DE 2-HYDROXYTÉTRAHYDROTHIÉNOPYRIDINE OPTIQUEMENT ACTIFS, LEUR PROCÉDÉ DE PRÉPARATION ET UTILISATION DANS LA FABRICATION DE MÉDICAMENT | [2018/10] | Examination procedure | 22.05.2017 | Examination requested [2018/10] | 22.05.2017 | Date on which the examining division has become responsible | 07.09.2018 | Amendment by applicant (claims and/or description) | 21.04.2020 | Despatch of a communication from the examining division (Time limit: M02) | 19.06.2020 | Reply to a communication from the examining division | 10.02.2021 | Communication of intention to grant the patent | 10.06.2021 | Fee for grant paid | 10.06.2021 | Fee for publishing/printing paid | 10.06.2021 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP11739328.0 / EP2532668 | Opposition(s) | 22.04.2022 | No opposition filed within time limit [2022/26] | Fees paid | Renewal fee | 22.05.2017 | Renewal fee patent year 03 | 22.05.2017 | Renewal fee patent year 04 | 22.05.2017 | Renewal fee patent year 05 | 22.05.2017 | Renewal fee patent year 06 | 22.05.2017 | Renewal fee patent year 07 | 29.01.2018 | Renewal fee patent year 08 | 04.12.2018 | Renewal fee patent year 09 | 24.12.2019 | Renewal fee patent year 10 | 18.01.2021 | Renewal fee patent year 11 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 28.01.2011 | AL | 21.07.2021 | AT | 21.07.2021 | CY | 21.07.2021 | CZ | 21.07.2021 | DK | 21.07.2021 | EE | 21.07.2021 | FI | 21.07.2021 | HR | 21.07.2021 | LT | 21.07.2021 | LV | 21.07.2021 | MC | 21.07.2021 | MK | 21.07.2021 | PL | 21.07.2021 | RO | 21.07.2021 | RS | 21.07.2021 | SI | 21.07.2021 | SK | 21.07.2021 | SM | 21.07.2021 | TR | 21.07.2021 | BG | 21.10.2021 | NO | 21.10.2021 | GR | 22.10.2021 | IS | 21.11.2021 | PT | 22.11.2021 | IE | 28.01.2022 | LU | 28.01.2022 | [2024/29] |
Former [2024/22] | HU | 28.01.2011 | |
AL | 21.07.2021 | ||
AT | 21.07.2021 | ||
CY | 21.07.2021 | ||
CZ | 21.07.2021 | ||
DK | 21.07.2021 | ||
EE | 21.07.2021 | ||
FI | 21.07.2021 | ||
HR | 21.07.2021 | ||
LT | 21.07.2021 | ||
LV | 21.07.2021 | ||
MC | 21.07.2021 | ||
MK | 21.07.2021 | ||
PL | 21.07.2021 | ||
RO | 21.07.2021 | ||
RS | 21.07.2021 | ||
SI | 21.07.2021 | ||
SK | 21.07.2021 | ||
SM | 21.07.2021 | ||
BG | 21.10.2021 | ||
NO | 21.10.2021 | ||
GR | 22.10.2021 | ||
IS | 21.11.2021 | ||
PT | 22.11.2021 | ||
IE | 28.01.2022 | ||
LU | 28.01.2022 | ||
Former [2024/20] | HU | 28.01.2011 | |
AL | 21.07.2021 | ||
AT | 21.07.2021 | ||
CY | 21.07.2021 | ||
CZ | 21.07.2021 | ||
DK | 21.07.2021 | ||
EE | 21.07.2021 | ||
FI | 21.07.2021 | ||
HR | 21.07.2021 | ||
LT | 21.07.2021 | ||
LV | 21.07.2021 | ||
MC | 21.07.2021 | ||
PL | 21.07.2021 | ||
RO | 21.07.2021 | ||
RS | 21.07.2021 | ||
SI | 21.07.2021 | ||
SK | 21.07.2021 | ||
SM | 21.07.2021 | ||
BG | 21.10.2021 | ||
NO | 21.10.2021 | ||
GR | 22.10.2021 | ||
IS | 21.11.2021 | ||
PT | 22.11.2021 | ||
IE | 28.01.2022 | ||
LU | 28.01.2022 | ||
Former [2024/18] | HU | 28.01.2011 | |
AL | 21.07.2021 | ||
AT | 21.07.2021 | ||
CZ | 21.07.2021 | ||
DK | 21.07.2021 | ||
EE | 21.07.2021 | ||
FI | 21.07.2021 | ||
HR | 21.07.2021 | ||
LT | 21.07.2021 | ||
LV | 21.07.2021 | ||
MC | 21.07.2021 | ||
PL | 21.07.2021 | ||
RO | 21.07.2021 | ||
RS | 21.07.2021 | ||
SI | 21.07.2021 | ||
SK | 21.07.2021 | ||
SM | 21.07.2021 | ||
BG | 21.10.2021 | ||
NO | 21.10.2021 | ||
GR | 22.10.2021 | ||
IS | 21.11.2021 | ||
PT | 22.11.2021 | ||
IE | 28.01.2022 | ||
LU | 28.01.2022 | ||
Former [2023/09] | AL | 21.07.2021 | |
AT | 21.07.2021 | ||
CZ | 21.07.2021 | ||
DK | 21.07.2021 | ||
EE | 21.07.2021 | ||
FI | 21.07.2021 | ||
HR | 21.07.2021 | ||
LT | 21.07.2021 | ||
LV | 21.07.2021 | ||
MC | 21.07.2021 | ||
PL | 21.07.2021 | ||
RO | 21.07.2021 | ||
RS | 21.07.2021 | ||
SI | 21.07.2021 | ||
SK | 21.07.2021 | ||
SM | 21.07.2021 | ||
BG | 21.10.2021 | ||
NO | 21.10.2021 | ||
GR | 22.10.2021 | ||
IS | 21.11.2021 | ||
PT | 22.11.2021 | ||
IE | 28.01.2022 | ||
LU | 28.01.2022 | ||
Former [2022/46] | AL | 21.07.2021 | |
AT | 21.07.2021 | ||
CZ | 21.07.2021 | ||
DK | 21.07.2021 | ||
EE | 21.07.2021 | ||
FI | 21.07.2021 | ||
HR | 21.07.2021 | ||
LT | 21.07.2021 | ||
LV | 21.07.2021 | ||
MC | 21.07.2021 | ||
PL | 21.07.2021 | ||
RO | 21.07.2021 | ||
RS | 21.07.2021 | ||
SI | 21.07.2021 | ||
SK | 21.07.2021 | ||
SM | 21.07.2021 | ||
BG | 21.10.2021 | ||
NO | 21.10.2021 | ||
GR | 22.10.2021 | ||
IS | 21.11.2021 | ||
PT | 22.11.2021 | ||
LU | 28.01.2022 | ||
Former [2022/39] | AL | 21.07.2021 | |
AT | 21.07.2021 | ||
CZ | 21.07.2021 | ||
DK | 21.07.2021 | ||
EE | 21.07.2021 | ||
FI | 21.07.2021 | ||
HR | 21.07.2021 | ||
LT | 21.07.2021 | ||
LV | 21.07.2021 | ||
MC | 21.07.2021 | ||
PL | 21.07.2021 | ||
RO | 21.07.2021 | ||
RS | 21.07.2021 | ||
SI | 21.07.2021 | ||
SK | 21.07.2021 | ||
SM | 21.07.2021 | ||
BG | 21.10.2021 | ||
NO | 21.10.2021 | ||
GR | 22.10.2021 | ||
IS | 21.11.2021 | ||
PT | 22.11.2021 | ||
Former [2022/29] | AL | 21.07.2021 | |
AT | 21.07.2021 | ||
CZ | 21.07.2021 | ||
DK | 21.07.2021 | ||
EE | 21.07.2021 | ||
FI | 21.07.2021 | ||
HR | 21.07.2021 | ||
LT | 21.07.2021 | ||
LV | 21.07.2021 | ||
PL | 21.07.2021 | ||
RO | 21.07.2021 | ||
RS | 21.07.2021 | ||
SI | 21.07.2021 | ||
SK | 21.07.2021 | ||
SM | 21.07.2021 | ||
BG | 21.10.2021 | ||
NO | 21.10.2021 | ||
GR | 22.10.2021 | ||
IS | 21.11.2021 | ||
PT | 22.11.2021 | ||
Former [2022/25] | AT | 21.07.2021 | |
CZ | 21.07.2021 | ||
DK | 21.07.2021 | ||
EE | 21.07.2021 | ||
FI | 21.07.2021 | ||
HR | 21.07.2021 | ||
LT | 21.07.2021 | ||
LV | 21.07.2021 | ||
PL | 21.07.2021 | ||
RO | 21.07.2021 | ||
RS | 21.07.2021 | ||
SK | 21.07.2021 | ||
SM | 21.07.2021 | ||
BG | 21.10.2021 | ||
NO | 21.10.2021 | ||
GR | 22.10.2021 | ||
IS | 21.11.2021 | ||
PT | 22.11.2021 | ||
Former [2022/24] | AT | 21.07.2021 | |
CZ | 21.07.2021 | ||
DK | 21.07.2021 | ||
EE | 21.07.2021 | ||
FI | 21.07.2021 | ||
HR | 21.07.2021 | ||
LT | 21.07.2021 | ||
LV | 21.07.2021 | ||
PL | 21.07.2021 | ||
RO | 21.07.2021 | ||
RS | 21.07.2021 | ||
SK | 21.07.2021 | ||
BG | 21.10.2021 | ||
NO | 21.10.2021 | ||
GR | 22.10.2021 | ||
IS | 21.11.2021 | ||
PT | 22.11.2021 | ||
Former [2022/21] | AT | 21.07.2021 | |
DK | 21.07.2021 | ||
FI | 21.07.2021 | ||
HR | 21.07.2021 | ||
LT | 21.07.2021 | ||
LV | 21.07.2021 | ||
PL | 21.07.2021 | ||
RS | 21.07.2021 | ||
BG | 21.10.2021 | ||
NO | 21.10.2021 | ||
GR | 22.10.2021 | ||
IS | 21.11.2021 | ||
PT | 22.11.2021 | ||
Former [2022/11] | AT | 21.07.2021 | |
FI | 21.07.2021 | ||
HR | 21.07.2021 | ||
LT | 21.07.2021 | ||
LV | 21.07.2021 | ||
PL | 21.07.2021 | ||
RS | 21.07.2021 | ||
BG | 21.10.2021 | ||
NO | 21.10.2021 | ||
GR | 22.10.2021 | ||
IS | 21.11.2021 | ||
PT | 22.11.2021 | ||
Former [2022/09] | AT | 21.07.2021 | |
FI | 21.07.2021 | ||
LT | 21.07.2021 | ||
RS | 21.07.2021 | ||
BG | 21.10.2021 | ||
NO | 21.10.2021 | ||
PT | 22.11.2021 | ||
Former [2022/08] | AT | 21.07.2021 | |
FI | 21.07.2021 | ||
LT | 21.07.2021 | ||
BG | 21.10.2021 | ||
NO | 21.10.2021 | ||
Former [2022/07] | AT | 21.07.2021 | |
LT | 21.07.2021 | ||
NO | 21.10.2021 | Documents cited: | Search | [I]EP0421861 (SANOFI SA [FR]) [I] 1-9 * page 4, line 43 - page 5, line 14 * * page 9; example 19 * * page 18, lines 22-28 *; | [A]CN101591344 (LIANYUNGANG HENGBANG PHARMACEU [CN]) [A] 1-9 * abstract ** claims 1-6 * | by applicant | US5190938 | WO9749397 | US5874581 | - LANCET, (1996), vol. 348, page 1329 | - THROMB HAEMOST, (2000), vol. 84, page 891 | - J PHARMACOL EXP THER, (2006), vol. 319, page 1467 | - CARDIOVASCULAR DRUG REVIEWS, (1993), vol. 11, page 180 | - CIRCULATION, (2004), vol. 109, page 166 | - N ENGL J MED, (2007), vol. 357, page 2001 | - NATURE, (1962), vol. 194, no. 4832, page 927 | - DRUG METAB REV, (2005), vol. 37, no. 2, page 99 | - DRUG METAB DISP, (2002), vol. 30, page 1288 | CN20081097756 |